Titration of Continuous Positive Airway Pressure Could Predict Success of Oral Appliance to Treat Sleep Apnea
Optimal Titration of Continuous Positive Airway Pressure Could Predict Success of Oral Appliance to Treat Obstructive Sleep Apnea Syndrome
1 other identifier
interventional
60
1 country
1
Brief Summary
Background: The oral appliances have been increasingly used in the treatment of primary snoring and in patients with mild obstructive sleep apnea syndrome besides being treatment options in adults with moderate to severe sleep apnea who did not accept or adapt to continuous positive airway pressure (CPAP). It is not well established yet in the literature, which patients with mild to moderate OSA will present a good response to treatment with oral appliances. Objective: To determine a value of CPAP pressure that correlates with a favorable response to the use of oral appliance in patients with mild to moderate sleep apnea. Patients and Methods: Two groups of 30 male patients (25-65 years, body mass index \< 35 kg/m2) will be selected: the first group with an apnea-hypopnea index (AHI) between 5 and 15 events per hour of sleep and the second one with an AHI between 15 and 30 events per hour of sleep. Each patient will undergo three polysomnographic recordings (baseline, CPAP titration, after two months of treatment with oral appliance). Subjective (sleep disorders questionnaire, the Epworth Sleepiness Scale, and sleep diaries) and objective (polysomnography) parameters of sleep will be evaluated, besides the quality of life (SF-36), mood (POMS), and anthropometric measurements (neck circumference and craniofacial characteristic). Good response to treatment with the AIO will be considered as a 50% reduction in the baseline AHI index or AHI after treatment less than 5 events per hour of sleep.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 14, 2011
CompletedFirst Posted
Study publicly available on registry
April 18, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedOctober 26, 2011
October 1, 2011
1.1 years
April 14, 2011
October 25, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Objective sleep parameters
polysomnographic date of sleep stages percentages, sleep efficience, arousals, apnea-hypopnea index, oxyhemoglobin saturation
two months after the baseline recording
Secondary Outcomes (2)
Subjective sleep parameters
two months after the baseline recording
Quality of life, mood, and anthropometric measurements
two months after the baseline recording
Interventions
Anterior mandibular repositioner: used for two months
Eligibility Criteria
You may qualify if:
- Male subjects aged between 25 and 65 years old
- Epworth sleepiness Scale \> 9
- Apnea-hypopnea index between 5 and 30
You may not qualify if:
- Presence of clinical disease (chronic obstructive pulmonary disease, asthma) and other sleep disorders.
- Presence of anatomical obstructive upper airway, tonsil grade III e IV, septal deviation and grade III that may affect the outcome of CPAP
- Loss of posterior dental support to undermine the retention of oral appliance
- Active of periodontal disease, compared Dental crow/dental root less than or equal to 1 (c/r ≤ 1) need primary dental care (cavities, root canal treatment or retreatment, dentures, i.e. outlying), open bite
- Protrusive displacement lass then five millimeters
- Limited mouth opening
- Alcoholism
- Use of sleep-inducing medications
- Habits or occupation that lead to sleep deprivation or alteration of the sleep-wake cycle
- Intolerance to CPAP
- Obesity grade II (moderate) or III (severe)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto do Sono/ Associação Fundo de Incentivo a Psicofarmacologia
São Paulo, São Paulo, 04023-062, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lia Rita A Bittencourt, MD, PhD
Federal University of São Paulo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
April 14, 2011
First Posted
April 18, 2011
Study Start
October 1, 2010
Primary Completion
November 1, 2011
Last Updated
October 26, 2011
Record last verified: 2011-10